Literature DB >> 16785572

Detailed analysis of intrahepatic CD8 T cells in the normal and hepatitis C-infected liver reveals differences in specific populations of memory cells with distinct homing phenotypes.

Mathis Heydtmann1, Debbie Hardie, Philip L Shields, Jeff Faint, Christopher D Buckley, James J Campbell, Michael Salmon, David H Adams.   

Abstract

In hepatitis C virus (HCV) infection the immune response is ineffective, leading to chronic hepatitis and liver damage. Primed CD8 T cells are critical for antiviral immunity and subsets of circulating CD8 T cells have been defined in blood but these do not necessarily reflect the clonality or differentiation of cells within tissue. Current models divide primed CD8 T cells into effector and memory cells, further subdivided into central memory (CCR7+, L-selectin+), recirculating through lymphoid tissues and effector memory (CCR7-, L-selectin-) mediating immune response in peripheral organs. We characterized CD8 T cells derived from organ donors and patients with end-stage HCV infection to show that: 1) all liver-infiltrating CD8 T cells express high levels of CD11a, indicating the effective absence of naive CD8 T cells in the liver. 2) The liver contains distinct subsets of primed CD8+ T cells including a population of CCR7+ L-selectin- cells, which does not reflect current paradigms. The expression of CCR7 by these cells may be induced by the hepatic microenvironment to facilitate recirculation. 3) The CCR7 ligands CCL19 and CCL21 are present on lymphatic, vascular, and sinusoidal endothelium in normal liver and in patients with HCV infection. We suggest that the recirculation of CCR7+/L-selectin- intrahepatic CD8 T cells to regional lymphoid tissue will be facilitated by CCL19 and CCL21 on hepatic sinusoids and lymphatics. This centripetal pathway of migration would allow restimulation in lymph nodes, thereby promoting immune surveillance in normal liver and renewal of effector responses in chronic viral infection.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16785572     DOI: 10.4049/jimmunol.177.1.729

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  23 in total

Review 1.  Functional role of chemokines in liver disease models.

Authors:  Hacer Sahin; Christian Trautwein; Hermann E Wasmuth
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-10-26       Impact factor: 46.802

Review 2.  The role of chemokines in the recruitment of lymphocytes to the liver.

Authors:  Ye H Oo; Shishir Shetty; David H Adams
Journal:  Dig Dis       Date:  2010-05-07       Impact factor: 2.404

Review 3.  Viral vector vaccines make memory T cells against malaria.

Authors:  Arturo Reyes-Sandoval; John T Harty; Stephen M Todryk
Journal:  Immunology       Date:  2007-06       Impact factor: 7.397

4.  CCL19 as a Chemokine Risk Factor for Posttreatment Lyme Disease Syndrome: a Prospective Clinical Cohort Study.

Authors:  John N Aucott; Mark J Soloski; Alison W Rebman; Lauren A Crowder; Lauren J Lahey; Catriona A Wagner; William H Robinson; Kathleen T Bechtold
Journal:  Clin Vaccine Immunol       Date:  2016-09-06

Review 5.  Effector CD8 T cell trafficking within the liver.

Authors:  Luca G Guidotti; Matteo Iannacone
Journal:  Mol Immunol       Date:  2012-11-10       Impact factor: 4.407

6.  A Model of Dormant-Emergent Metastatic Breast Cancer Progression Enabling Exploration of Biomarker Signatures.

Authors:  Amanda M Clark; Manu P Kumar; Sarah E Wheeler; Carissa L Young; Raman Venkataramanan; Donna B Stolz; Linda G Griffith; Douglas A Lauffenburger; Alan Wells
Journal:  Mol Cell Proteomics       Date:  2018-01-20       Impact factor: 5.911

Review 7.  Chemokines in the immunopathogenesis of hepatitis C infection.

Authors:  Mathis Heydtmann; David H Adams
Journal:  Hepatology       Date:  2009-02       Impact factor: 17.425

8.  Human liver-resident CD56(bright)/CD16(neg) NK cells are retained within hepatic sinusoids via the engagement of CCR5 and CXCR6 pathways.

Authors:  Kelly Hudspeth; Matteo Donadon; Matteo Cimino; Elena Pontarini; Paolo Tentorio; Max Preti; Michelle Hong; Antonio Bertoletti; Silvio Bicciato; Pietro Invernizzi; Enrico Lugli; Guido Torzilli; M Eric Gershwin; Domenico Mavilio
Journal:  J Autoimmun       Date:  2015-08-30       Impact factor: 7.094

9.  Functional restoration of HCV-specific CD8 T cells by PD-1 blockade is defined by PD-1 expression and compartmentalization.

Authors:  Nobuhiro Nakamoto; David E Kaplan; Jennifer Coleclough; Yun Li; Mary E Valiga; Mary Kaminski; Abraham Shaked; Kim Olthoff; Emma Gostick; David A Price; Gordon J Freeman; E John Wherry; Kyong-Mi Chang
Journal:  Gastroenterology       Date:  2008-02-17       Impact factor: 22.682

10.  Imaging of effector memory T cells during a delayed-type hypersensitivity reaction and suppression by Kv1.3 channel block.

Authors:  Melanie P Matheu; Christine Beeton; Adriana Garcia; Victor Chi; Srikant Rangaraju; Olga Safrina; Kevin Monaghan; Marc I Uemura; Dan Li; Sukumar Pal; Luis M de la Maza; Edwin Monuki; Alexander Flügel; Michael W Pennington; Ian Parker; K George Chandy; Michael D Cahalan
Journal:  Immunity       Date:  2008-10-02       Impact factor: 31.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.